|
References: S
- Sadeh, A., M. Klitzke, T. F. Anders, and C. Acebo. 1995. Case study: Sleep and aggressive behavior in a blind retarded adolescent. A concomitant schedule disorder? J. Am. Acad. Child Adolesc.
Psychiatry 34:820-824.
- Safer, D. J., and J. M. Krager. 1988. A survey of medication treatment for hyperactive/inattentive students. JAMA 260:2256-2258.
- Schmitt, B. D. 1995. Nocturnal enuresis: Finding the treatment that fits the child. Contemp. Pediatr. 12:3-15.
- Scholomskas, A. J. 1990. Mania in a panic disorder patient treated with fluoxetine. Am. J. Psychiatry 147:1090-1091.
- Schopmeyer, B., and F. Lowe. 1992. The fragile X child. San Diego: Singular Publishing Group.
- Selinger, G. M., A. Hornstein, J. Flax, J. Herbert, and K. Schroeder. 1992. Fluoxetine improves emotional incontinence. Brain Inj. 6:267-270.
- Shapiro, A. K., E. S. Shapiro, J. G. Young, and T. E. Feinberg. 1988. Gilles de la Tourette syndrome, 2d ed. New York: Raven Press, pp. 405-410.
- Singer, H. S., J. Brown, S. Quaskey, L. A. Rosenberg, E. D. Mellits, and M. B. Denckla. 1995. The treatment of attention deficit hyperactivity disorder in Tourette's syndrome: A double-blind
placebo-controlled study with clonidine and desipramine. Pediatrics 95:74-82.
- Sloan, R. L., K. W. Brown, and B. Pentland. 1992. Fluoxetine as a treatment for emotional lability after brain injury. Brain Inj. 6:315-319.
- Solanto, M. V. 1998. Neuropsychopharmacological mechanisms of stimulant drug action in attention-deficit hyperactivity disorder: A review and integration. Behav. Brain Res. 94:127-152.
- Sondheimer, J. M. 1994. Gastroesophageal reflux in children: Clinical presentation and diagnostic evaluation. Gastrointest. Endosc. Clin. N. Am. 4:55-74.
- Sovner, R., and R. J. Pary. 1993. Affective disorders in developmentally disabled persons. In J. L. Matson and R. P. Barrett (eds.), Psychopathology in the mentally retarded. Needham Heights, Mass.:
Allyn & Bacon, pp. 87-147.
- Spiridigliozzi, G. A., A. M. Lachiewicz, C. S. MacMurdo, A. D. Vizoso, C. M. O'Donnell, A. McConkie-Rosell, and D. J. Burges. 1994. Educating boys with fragile X syndrome: A guide for parents and
professionals. Durham: Duke University Medical Center.
- Staubli, U., G. Rogers, and G. Lynch. 1994. Facilitation of glutamate receptors enhances memory. Proc. Natl. Acad. Sci. USA 91:777-781.
- Steiner, M., S. Steinberg, D. Stewart, D. Carter, C. Berger, R. Reid, D. Grover, and D. Streiner. 1995. Fluoxetine in the treatment of premenstrual dysphoria. N. Engl. J. Med. 332:1529-1534.
- Steingard, R., J. Biederman, J. Spencer, T. Wilens, and A. Gonzalez. 1993. Comparison of clonidine response in treatment of attention deficit hyperactivity disorder with and without comorbid tic
disorders. J. Am. Acad. Child Adolesc. Psychiatry 32:350-353.
- Steingard, R. J., M. Goldberg, D. Lee, and D. R. Demaso. 1994. Adjunctive clonazepam treatment of tic symptoms in children with comorbid tic disorders and ADHD. J. Am. Acad. Child Adolesc. Psychiatry
33:394-398.
- Steingard, R. J., B. Zimnitzky, D. R. DeMaso, M. L. Bauman, and J. P. Bucci. 1997. Sertraline treatment of transition-associated anxiety and agitation in children with autistic disorder. J. Child
Adolesc. Psychopharmacol. 7:9-15.
- Stewart, J. T., W. C. Myers, R. C. Burket, and W. B. Lyles. 1990. A review of the pharmacotherapy of aggression in children and adolescents. J. Am. Acad. Child Adolesc. Psychiatry 29:269-277.
- Swann, A. C., C. L. Bowden, and D. Morris. 1997. Depression during mania: Treatment response to lithium and divalproex. Arch. Gen. Psychiatry 54:37-42.
- Swanson, J., S. Wigal, L. Greenhill, R. Browne, B. Waslick, M. Lerner, L. Williams, D. Flynn, D. Agler, K. L. Crowley, E. Fineberg, R. Regino, M. Baren, and D. Cantwell. 1998. Objective and subjective
measures of the pharmacodynamic effects of Adderall in the treatment of children with ADHD in a controlled laboratory classroom setting. Psychopharmacol. Bull. 34:55-60.
- Swanson, J. M., D. Flockhart, D. Udrea, D. Cantwell, D. Connor, and L. Williams. 1995. Clonidine and the treatment of ADHD: Questions about safety and efficacy. J. Child Adolesc. Psychopharmacol.
5:301-304.
|
This article is not intended to give medical advice for individual cases. Any change in medical treatment
should be done in consultation with appropriate medical personnel. This article is written for medical professionals. Some of the terms will be unfamiliar to those who are not trained in medical fields.
*This article is from the chapter on treatment in the 3rd edition of Fragile X Syndrome: Diagnosis, Treatment, and Research edited
by Randi Jenssen Hagerman, M.D. and Paul Hagerman, M.D., Ph.D., to be published May 2002. It is included with permission from The Johns Hopkins University Press. References to other chapters refer to chapters in
the book which are not included as part of this website.
The complete 3rd edition of Fragile X Syndrome: Diagnosis, Treatment, and Research can be ordered from the National Fragile X Foundation by calling
1-800-688-8765 or from The Johns Hopkins University Press at 1-800-537-5487.
|
|
Medical Follow-up Pharmacotherapy Future Prospects
Outline Medications Medical Conditions
References: A, B, C, D, EF, G, H, IJ, K, L, M, NOP, QR, S, T, UVWXYZ
|
